Medicare’s blame game
A Stanford researcher and his colleague got access to data showing the inner workings of an influential committee advising Medicare. They found that bias among its members has different effects from what critics claim.
CRISPR helps reveal drug targets for ALS
Through genome editing, scientists at Stanford have pinpointed genes that reveal mechanistic details of ALS and may even protect against the degeneration of neurons.
Misbehaving cells predict relapse in leukemia
Analyzing individual cancer cells has enabled Stanford researchers to identify the small population of cells that spur relapse in some children with leukemia.
Reducing side effects of a cancer therapy
Stanford scientists created an odd couple: a modified version of an immune-signaling protein and a coordinately modified receptor for this protein. The two bind only to each other, easing an advanced anti-cancer therapy’s side effects.
More premature births after recent deployment
Giving birth soon after military deployment is linked to greater risk of premature delivery, a Stanford study of U.S. servicewomen found, but deployment history itself does not raise prematurity risk.
Antibody treatment for ‘bubble boy’ disease
In a clinical trial, participants were given an antibody to CD117, a cell surface marker, in an effort to wipe out their defective blood stem cells without high-risk chemotherapy or radiation.
Progress toward precision health
A perspective piece from Stanford scientists provides an overview of the value of precision health, its progress, challenges and how it can improve health at the individual and population level.
Magazine explores new frontiers
The winter issue of Stanford Medicine magazine highlights science that pushes boundaries to save lives and considers ethical questions that are a fundamental part of research.
How our brains prepare for action
Mentally running through a routine improves performance, but how that works isn’t clear. Now, a new tool — brain-machine interface — suggests the answer lies in how our brains prepare for action.
Ioannidis on antidepressant efficacy
In a highly comprehensive meta-analysis of more than 500 clinical trials, researchers from around the world have drawn conclusions about the efficacy of 21 different antidepressants.